CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study.

A Figueiras, A Estany-Gestal, C Aguirre, B Ruiz, X Vidal, A Carvajal, I Salado, A Salgado-Barreira, L Rodella, U Moretti, L Ibáñez

Research output: Contribution to journalArticleResearch

20 Citations (Scopus)
Original languageEnglish
Pages (from-to)66-73
JournalPharmacogenetics and Genomics
Issue number2
Publication statusPublished - 1 Jan 2016

Cite this